Contact this trialFirst, we need to learn more about you.
Virus Therapy
Pexa-Vec for Colorectal Cancer
Recruiting1 awardPhase 1 & 2
Bethesda, Maryland
This trial is testing whether Pexa-Vec, a thymidine kinase gene-inactivated oncolytic vaccinia virus, can enhance the anti-tumor immunity induced by Pexa-Vec oncolytic viral therapy when combined with immune checkpoint inhibition.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service